APP and Alzheimer disease: Studies in AD mouse models that are based on rare familial mutations associated with high risk for AD (i.e., mice overexpressing mutant amyloid precursor protein and/or presenilin) have indicated that eIF2α hyperphosphorylation can be seen in some of these disease models as well [6–8].